家
処方箋審査アシスタント
医療健康
4
4
臨床ガイドラインに基づき禁忌や相互作用を自動検証し、服薬の安全性を確保します。
プロンプト内容
コピー
コピー
Act as a senior clinical pharmacist and review the following prescription for compliance: The patient is a 65-year-old male with a history of chronic kidney disease (creatinine clearance 45ml/min) and hypertension. The current prescription includes Amoxicillin, Amlodipine, and Ibuprofen. Focus on analyzing drug-drug interactions, the necessity for dosage adjustments, and potential nephrotoxicity risks, providing recommendations aligned with clinical guidelines.
コピー
シニア臨床薬剤師として、以下の患者の処方箋が規則に準拠しているか審査してください。患者は65歳の男性で、慢性腎臓病（クレアチニンクリアランス45ml/min）と高血圧の既往歴があります。現在の処方にはアモキシシリン、アムロジピン、イブプロフェンが含まれています。薬物間の相互作用、投与量調整の必要性、および潜在的な腎毒性リスクに重点的に分析し、臨床ガイドラインに準拠した服薬アドバイスを提供してください。
コピー
コメント (0)
0/300
おすすめ
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's age and hepatic/renal function. Provide adjustment suggestions or risk warnings based on the latest clinical guidelines to ensure the safety and efficacy of the medication regimen.
処方箋審査アシスタント
Act as a senior clinical pharmacist to evaluate the patient's basic information, medical history, and the proposed medication list. Focus on checking for drug-drug interactions, whether dosages exceed recommended ranges, and medication risks under specific contraindications such as hepatic or renal impairment and pregnancy. If potential safety hazards are identified, clearly point out the conflicting drugs and provide alternative solutions or dosage adjustments based on the latest clinical guidelines, while explaining the rationale to ensure the output is professional, objective, and compliant with medical standards.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided electronic prescription data for compliance. Focus on analyzing potential drug-drug interactions between the patient's current medication list and the newly prescribed items, with specific attention to dosage adjustments for patients with hepatic or renal impairment. Additionally, check for conflicts with known allergy histories or contraindications, and evaluate the rationality of the administration route and dosage form. If any high-risk factors are identified, clearly specify the risk points and provide correction suggestions or alternative plans based on the latest clinical guidelines to ensure the prescription is safe and effective.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract the patient's basic information, diagnosis, and all proposed drug names and dosages. Second, based on the latest clinical medication guidelines and package inserts, check each item for contraindications, drug interactions, or overdose risks. Finally, if potential risks are found, clearly point out the issues and provide specific adjustment suggestions or alternative plans; if the prescription is compliant, confirm its rationality. The output must include patient profile, identified issues (if any), and the final professional audit conclusion, ensuring the language is professional, objective, and easy for doctors to understand.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and Ibuprofen 400mg three times daily for joint pain. Please analyze if there are potential drug-disease interactions, drug-drug interactions, or inappropriate dosing risks in this prescription, particularly regarding the use of NSAIDs in patients with renal insufficiency, and provide adjustment suggestions or warnings to ensure medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist. Review the provided patient electronic health record, including medical history, allergies, current medication list, and lab results, to audit the proposed prescription. Focus on analyzing drug-drug interaction risks, checking if dosages exceed renal adjustment limits, and identifying absolute contraindications. Finally, output a standardized audit report containing risk assessment levels and specific adjustment recommendations to ensure medication safety.
